GlobeNewswire 30/04 Press Release: Annual General Meeting of April 30, 2024
TeleTrader 25/04 Europe opens mostly down after corporate earnings
TeleTrader 25/04 Europe down in premarket as financial results pour in
TeleTrader 25/04 Sanofi books net sales of €10.5B in Q1, up 2.4%
GlobeNewswire 25/04 Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
GlobeNewswire 23/04 Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
GlobeNewswire 17/04 IGM Biosciences Announces Refocusing of Sanofi Collaboration
GlobeNewswire 17/04 Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...
GlobeNewswire 16/04 2024 DTA Summit Agenda is LIVE!!
GlobeNewswire 10/04 Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Upda...
GlobeNewswire 09/04 Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targe...
GlobeNewswire 29/03 Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 22/03 Press Release: Availability of the Q1 2024 Memorandum for modelling purposes
GlobeNewswire 14/03 MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Busi...
GlobeNewswire 14/03 SMDG Announces Appointment of Industry Leader Dr. Zsuzsanna Devecseri to the Board of Directors
GlobeNewswire 11/03 Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance ...
GlobeNewswire 05/03 Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (F...
GlobeNewswire 28/02 Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized ...
GlobeNewswire 27/02 Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlig...
GlobeNewswire 24/02 Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significa...
GlobeNewswire 23/02 Press Release: Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” co...
GlobeNewswire 23/02 Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflam...
GlobeNewswire 23/02 Press Release: Dupixent® sBLA accepted for FDA Priority Review for treatment of COPD with type 2 inf...
GlobeNewswire 22/02 Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoi...
GlobeNewswire 22/02 Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Bus...